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ABSTRACT
Home oxygen therapy allows patients requiring long-
term oxygen therapy to receive care at home and helps 
improve the prognosis of patients with chronic respira-
tory failure. The usage conditions of oxygen concentra-
tors, which are used to supply gaseous oxygen, and the 
effects of oxygen inhaled at a prescribed flow rate have 
not been confirmed in adequate detail. As a result of ad-
vances in information and communications technology, 
internet communication functions can now be incorpo-
rated into medical devices installed in patients’ homes. 
This allows time-series data on oxygen concentrator us-
age and biological variables to be stored on a server and 
accessed remotely by health care providers, enabling 
them to check the validity of home oxygen therapy and 
intervene appropriately. In Japan, telemonitoring of 
home oxygen therapy is covered by social insurance 
systems and is recognized as a new medical technology. 
This article reviews the usefulness of telemonitoring 
of home oxygen therapy and describes the cloud-based 
analytical system we have developed.
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Home oxygen therapy (HOT) plays an important role 
in home medical care and provides long-term oxygen 
therapy to improve patients’ quality of life (QOL) and 
prognosis. HOT has been covered by social insurance 
programs in Japan since 1985 and is administered to 
many patients. In Japan, indications for HOT include 
chronic respiratory failure, chronic heart failure with 
Cheyne-Stokes respiration, pulmonary hypertension, 
and cyanotic congenital heart diseases. The vast major-
ity of patients with chronic respiratory failure require 
HOT, and it improves the prognosis in these patients.1–3 
Regarding the duration of oxygen inhalation, a study 
in patients with chronic obstructive pulmonary disease 
(COPD) with chronic respiratory failure reported that 
the prognosis was better in the group that received con-
tinuous, 24-hour oxygen inhalation than in the group 
that received nocturnal oxygen inhalation.4 A cost-
effectiveness study also found better cost-effectiveness 
in the continuous oxygen inhalation group than in the 
nocturnal oxygen inhalation group.5 Health economic 
study has shown the importance of inhaling oxygen 
over long periods of time; however, some patients did 
not use oxygen inhalation long enough and setting of 
oxygen flow rate was not optimal.
Telemonitoring is a new medical tool that has 
emerged from developments in information and com-
munications technology (ICT). For example, the use of 
cardiac pacemakers and implantable cardiac defibrilla-
tors compatible with telemonitoring has been reported 
to reduce mortality, the number of hospitalizations, and 
the frequency of face-to-face clinical consultations.6–8 
In cardiac diseases, telemonitoring improves patients’ 
QOL and prognosis.6–8
Recently, social insurance programs in Japan 
started covering the cost of telemonitoring of HOT. To 
request social insurance reimbursement for telemonitor-
ing of HOT, a care provider is required to remotely 
monitor pulse rates, percutaneous arterial blood oxygen 
saturation (SpO2) levels9 (measured with a pulse oxime-
ter), and the usage conditions of an oxygen concentrator 
and also needs to provide the patient with instructions 
based on the monitoring. This article describes the 
usefulness of telemonitoring of HOT and introduces 
an analytical system that we have developed to enable 
health care providers to use their own computers to 
analyze integrated time-series data from telemonitoring.
USEFULNESS OF TELEMONITORING OF HOT
Below, studies are discussed that have examined 
the ability of telemonitoring of HOT to improve 
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health-related QOL (HRQOL), prevent acute exacerba-
tions, and reduce the number of emergency department 
visits and hospitalizations in patients with chronic respi-
ratory failure. The efficacy of telemonitoring in patients 
receiving HOT for other diseases remains unclear and 
further research is needed.
Effects on HRQOL
A limited number of studies examined patients receiv-
ing HOT for chronic respiratory failure (Table 1), and 
many studies compared HRQOL scores before and after 
patients with COPD started receiving telemonitoring 
without HOT.10 Long-term oxygen therapy is often re-
quired when COPD worsens to its most severe level.11, 12
A meta-analysis of reports on telemonitoring in 
patients with COPD showed significant improvements 
in mental health-related QOL scores,13 and an interven-
tion involving telemonitoring of blood pressure, heart 
rate, and SpO2 in patients with COPD demonstrated 
improvements in HRQOL scores measured with the 
St George’s Respiratory Questionnaire for patients 
with COPD (SGRQ-C),14 the EuroQol 5-dimension 
questionnaire (EQ-5D),15 and the Hospital Anxiety and 
Depression Scale (HADS).16, 17 Another intervention 
involving telemonitoring of symptoms, spirometer read-
outs, and SpO2 levels in patients with COPD showed an 
improvement in HRQOL measured with the 15D QoL 
questionnaire.18, 19 Additional studies showed that vari-
ous telemonitoring interventions improved the HRQOL 
of patients with COPD.20, 21 An interventional guidance 
based on telemonitoring of oxygen concentrator usage 
conditions, pulse rates, and SpO2 levels in patients 
receiving HOT for chronic respiratory failure was 
reported to improve vitality and mental health scores 
assessed with the Medical Outcome Study 36-Item 
Short Form Health Survey (SF-36).22 In contrast, some 
studies have found that telemonitoring does not improve 
HRQOL in patients with COPD.10, 23, 24 A systematic 
review attributed this finding to differences between 
studies in the methods used for telemonitoring in 
patients with COPD; specifically, some studies involved 
simple telemonitoring of biological variables, whereas 
others used the telemonitoring data to intervene.10 The 
usefulness of telemonitoring of HOT may depend on the 
different types of biological variables and instrument-
related information being monitored and the way 
health care providers intervene. Thus, future studies 
should evaluate which variables provide the most useful 
information.
Effects on the number of acute exacerbations, 
emergency department visits, and hospitalizations
Telemonitoring has been used mainly in patients with 
COPD who are not receiving HOT. A meta-analysis 
of reported studies involving telemonitoring and 
intervention in patients with COPD found significant 
improvements in the number of emergency department 
visits and hospitalizations,13 and a systemic review of 
telenursing of patients with COPD also found that tele-
monitoring of blood pressure, symptoms, SpO2 levels, 
and pulse rate decreased the number of hospitalizations, 
emergency department visits, and acute exacerbations.25 
However, a systematic review of studies on telemonitor-
ing and intervention in patients with COPD suggested 
that telemonitoring and intervention did not help prevent 
exacerbations.26
Only a small number of reports have described the 
effectiveness of telemonitoring of HOT in preventing 
Table 1. Characteristics of studies investigating the usefulness of telemonitoring of home oxygen therapy
Author Type of study No. of patients Variables monitored Significant improvements found
Kamei et al. (27) RCT 37 Blood pressure, pulse rate, SpO2,  symptoms, body weight
Number of acute exacerbations,  
hospitalizations, length of hospital stay
Segrelles Calvo et al. (28) Non-RCT 59 Blood pressure, pulse rate, SpO2,  peak flow, temperature
Number of acute exacerbations,  
emergency department visits,  
hospitalizations, length of hospital stay
Faria et al. (33) Non-RCT 35 Heart rate, SpO2, METS  (measured with an accelerometer) Adequate oxygen prescription
Ancochea et al. (29) RCT 240
Blood pressure, pulse rate, SpO2,  
spirometry data, respiratory rate,  
usage time of oxygen concentrator
None
Burioka et al. (22) Non-RCT 12 Pulse rate, SpO2,  usage time of oxygen concentrator
SF-36 scores of vitality and mental 
health
METS, metabolic equivalents; RCT, randomized controlled trial; SF-36, Medical Outcome Study 36-Item Short Form Health Survey; 
SpO2, percutaneous arterial blood oxygen saturation.
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acute exacerbations and reducing the number of 
emergency department visits and hospitalizations. A 
few studies have evaluated the effects of telemonitor-
ing in patients receiving HOT for chronic respiratory 
failure (Table 1). A study conducted in Japan showed 
that telenursing by telemonitoring patients with COPD 
receiving HOT (including assessing blood pressure, 
symptoms, SpO2, pulse rates, and body weight) resulted 
in significant decreases in the number of hospitaliza-
tions, the duration of hospital stays, and the number of 
acute exacerbations.27 Describing the findings of the 
PROMETE study, in which patients with severe COPD 
receiving HOT were advised to visit a hospital when 
telemonitoring detected a possible exacerbation of 
COPD, Segrelles Calvo et al. reported that telemonitor-
ing of blood pressure, SpO2, pulse rate, and peak flow 
data significantly reduced the number of emergency 
department visits and hospitalizations and the duration 
of hospital stays.28 In contrast, in a later study Ancochea 
et al. reported that telemonitoring of blood pressure, 
SpO2, pulse rate, respiratory rate, and spirometry data 
did not reduce the number of COPD-related emergency 
department visits or hospitalizations of patients with 
severe COPD receiving HOT.29
A study conducted in patients with severe COPD, 
some of whom were receiving HOT, found that 
telemonitoring of SpO2, spirometry, and symptoms 
combined with video interviews decreased the number 
of outpatient consultations in the telemonitoring group, 
whereas the rate of hospitalizations and time to first 
hospitalization did not differ from the control group.30 
Similarly, a study on telemonitoring of SpO2 and pulse 
rate data found a lower rehospitalization rate in the 
group of patients with severe COPD, some of whom 
were receiving HOT, than in the control group; in 
contrast, the study found no differences in the hospital-
ization rates or number of emergency department visits 
between the 2 groups.31
In conclusion, findings are inconsistent on whether 
or not telemonitoring of HOT is effective in preventing 
acute exacerbations and decreasing emergency depart-
ment visits and hospitalizations. Determining when and 
how to intervene on the basis of telemonitoring data is 
important and requires further research. Studies are also 
needed to identify criteria for when telemonitoring is 
indicated because patients receiving HOT are generally 
severely ill.
NEW SYSTEM FOR TELEMONITORING OF 
HOME OXYGEN THERAPY
As mentioned above, oxygen concentrators are used 
as the primary sources of gaseous oxygen in HOT. 
In Japan, new functions have been added to oxygen 
concentrators so that patients can use HOT comfort-
ably.32 Interviews during outpatient hospital visits are 
not sufficient for confirming in adequate detail the 
usage conditions of oxygen concentrators at home, 
and research has shown the difficulties associated with 
determining whether oxygen is inhaled at an appropri-
ate flow rate during HOT.33 To solve these problems, we 
have developed an analytical system that allows health 
care providers to use their own computers to analyze the 
usage conditions of oxygen concentrators and integrated 
time-series data consisting of pulse rates and SpO2 val-
ues measured by patients themselves with a dedicated 
pulse oximeter. Furthermore, in collaboration with a 
corporate partner we have used this system to develop 
an oxygen concentrator with an Internet-of-Things (IoT) 
function.
Various methods have been used for telemonitor-
ing of HOT in patients with chronic respiratory failure. 
The telemonitoring system we have developed is a new 
medical technology. It does not monitor the patient’s 
condition continuously but uses an internet-connected 
device to automatically save the time-series data on a 
dedicated server, which allows health care providers 
to use their own computers at any time to access and 
analyze the data (Fig. 1). These data include the device 
operating status and biological variables. Health care 
providers use the monitoring results to adapt the pa-
tients’ HOT parameters as necessary.
The oxygen concentrator we developed for 
telemonitoring of HOT (FH-100/5L, Fukuda Denshi, 
Tokyo) is covered by the social insurance system in 
Japan. The information on the oxygen concentrator and 
the biological variables measured by the patient at home, 
ie, SpO2 levels and pulse rates, are integrated by the part 
of the devices called the Fukuda Home Management 
System® (FHM-O2®, Fukuda Denshi) (Fig. 2). The 
HOT Careline® (Fukuda Denshi) comprises a cloud sys-
tem, which automatically stores the data on a dedicated 
server via the internet, and the telemonitoring part (Fig. 
1), which allows users to access the accumulated data 
on personal computers. After logging into a dedicated 
server online via the internet, our HOT telemonitoring 
allows for multifaceted actions, including: (i) checking 
the time periods and total time the oxygen concentrator 
was used; (ii) confirming the use of the prescribed flow 
rate for oxygen inhalation and the actual oxygen flow 
rates used; (iii) checking for hypoxemia (SpO2 ≤ 90%); 
and (iv) displaying self-measured SpO2 levels and pulse 
rates for each flow rate of inhaled oxygen in the form of 
a scatter plot. Because the device itself connects to the 
internet via the mobile phone network, patients are not 
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required to do anything more complicated than using a 
dedicated pulse oximeter (Anypal®, Fukuda Denshi).
As an example, Fig. 3 shows a telemonitoring 
screen of HOT displaying the device usage information 
for a 28-day period in a 78-year-old man receiving 
HOT for chronic respiratory failure due to COPD. After 
Fig. 1. Telemonitoring of home oxygen therapy. A conceptual diagram of telemonitoring. A communication card inserted into the 
medical device at home automatically uploads the operating status and measurement results to a dedicated server on a periodically basis 
by connecting to the internet (the so-called cloud system). The analysis software installed on the server is used to create charts to allow 
objective analysis of the stored time-series data. Health care providers can check the results and use them to support medical treatment 
of patients.
Fig. 2. An overview of the system used to integrate biological variables and usage information of an oxygen concentrator. The patient 
measures SpO2 levels and pulse rates with a dedicated pulse oximeter and inserts the pulse oximeter into the oxygen concentrator, which 
stores and integrates the usage data of the oxygen concentrator and biological variables from the pulse oximeter. The oxygen concentra-
tor connects to the internet via a mobile phone network that periodically and automatically uploads the integrated information to the 
server of the cloud system.
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logging into the dedicated server from a computer, the 
man’s health care provider can analyze any period and 
prescribe an oxygen inhalation flow rate. In general, 
at least 3 different flow rates are prescribed, ie, one at 
rest, one during exertion, and one during sleep. In the 
presented case, the prescribed oxygen flow rates are 
2 L/min at rest, 3 L/min during exertion, and 1.75 L/
min during sleep. The pie chart depicts the percentage 
of time that oxygen flowed at 2 different rates (rest and 
sleep) over the 28-day period and the percentage of 
time during which the oxygen concentrator was not 
used. The mean usage time during the period was 22.7 
h/day, indicating that the patient was using the system 
enough. Figure 4 shows a scatter plot of SpO2 levels on 
the vertical axis and pulse rates on the horizontal axis; 
the clustering of data in the upper left area is considered 
to indicate a favorable state. The colors of the squares 
show the oxygen flow rates at the time of measurement. 
The normal ranges for SpO2 and pulse rate are greater 
than 90% and below 100 beats/min, respectively. 
The patient’s health care provider confirmed with the 
patient that the SpO2 values less than or equal to 90% 
were measured after exertion; accordingly, health care 
provider reminded the patient to inhale oxygen at a 
flow rate of 3 L/min during exertion. The system allows 
health care providers to show analysis results directly 
to patients when giving them specific instructions and 
explaining them.
CONCLUSIONS
No consensus has been reached regarding the evaluation 
of telemonitoring of HOT because patients receiving 
this therapy are critically ill and have many comorbidi-
ties, and various methods are used for telemonitoring. 
Frequent monitoring is required to prevent acute 
exacerbations, emergency department visits, and 
hospitalizations, but providing frequent instruction and 
intervention on the basis of monitoring results is dif-
ficult. The above-mentioned good results found in some 
studies may be attributable to adequate instruction and 
intervention based on monitoring.
In general, the use of telemonitoring in HOT makes 
it easier to determine the usage of oxygen concentra-
tors and oxygen flow rates.33 HOT is less useful if a 
Fig. 3. Example usage conditions of an oxygen concentrator. The figure shows a health care provider’s view of an example analysis screen. 
The pie chart allows health care providers to check oxygen flow rates over 1 month and the percentage of time during which the oxygen 
concentrator was not used. The 78-year-old patient in this example used the oxygen concentrator adequately but did not use the 3 L/min 
oxygen flow rate prescribed for use during exertion. CSV, comma-separated values; SpO2, percutaneous arterial blood oxygen saturation.
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patient does not inhale oxygen at home for long enough. 
Therefore, an important benefit of using telemonitoring 
is the ability to easily examine usage of the oxygen 
concentrator. Moreover, telemonitoring allows for an 
objective analysis of the appropriateness of the pre-
scribed oxygen flow rates by using SpO2 and pulse rate 
data measured by patients themselves with dedicated 
pulse oximeters. Prolonged intervals between face-to-
face outpatient consultations made it difficult for care 
providers to understand patients’ conditions in a timely 
manner. Telemonitoring allows for closer monitoring 
and makes it possible to be longer intervals between 
hospital visits.
It should be noted that the telemonitoring of HOT 
approved in Japan does not provide continuous monitor-
ing. Therefore, it is not currently suitable for detecting 
acute exacerbations, and patients should be informed 
of this point. Nevertheless, telemonitoring of HOT can 
be expected to improve the HRQOL and prognosis of 
patients receiving HOT for home medical care in the 
future.
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